Shockwave Medical Provides Quarterly Earnings Release Dates for 2022

Rhea-AI Summary

Shockwave Medical, Inc. (Nasdaq: SWAV) announced the schedule for its upcoming quarterly earnings releases. The Fourth Quarter 2021 earnings will occur on February 17, 2022, followed by the First Quarter 2022 on May 9, 2022, Second Quarter 2022 on August 8, 2022, and Third Quarter 2022 on November 7, 2022. All calls are set for 4:30 p.m. ET. Investors can listen live or access archived webcasts at the company’s investor relations website.

Positive

• Scheduled earnings calls provide transparency for investors.
• The company is pioneering Intravascular Lithotripsy (IVL), enhancing treatment options for calcified cardiovascular disease.

Negative

• None.

SANTA CLARA, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, announced today that it expects to issue quarterly earnings releases after the market closes and hold conference calls at the times indicated on the following dates:

Fourth Quarter 2021 Earnings – Thursday, February 17, 2022 at 4:30 p.m. (ET)
First Quarter 2022 Earnings – Monday, May 9, 2022 at 4:30 p.m. (ET)
Second Quarter 2022 Earnings – Monday, August 8, 2022 at 4:30 p.m. (ET)
Third Quarter 2022 Earnings – Monday, November 7, 2022 at 4:30 p.m. (ET)

Investors interested in listening to the fourth quarter 2021 conference call at 4:30 p.m. eastern time on Thursday, February 17, 2022 may do so by dialing (866) 795-9106 for domestic callers or (470) 495-9173 for international callers, using conference ID: 6866777. Live and archived webcasts of all earnings events will also be made available at https://ir.shockwavemedical.com.

Dial-in information for future earnings calls will be provided at later dates.

About Shockwave Medical, Inc.
Shockwave Medical is focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. The company aims to establish a new standard of care for the interventional treatment of atherosclerotic cardiovascular disease through differentiated and proprietary local delivery of sonic pressure waves for the treatment of calcified plaque, which the company refers to as Intravascular Lithotripsy (IVL). IVL is a minimally invasive, easy-to-use and safe way to significantly improve patient outcomes. To view an animation of the IVL procedure and for more information, visit www.shockwavemedical.com.

Media Contact:
Scott Shadiow
sshadiow@shockwavemedical.com

Investor Contact:
Debbie Kaster
dkaster@shockwavemedical.com

FAQ

When is Shockwave Medical's Fourth Quarter 2021 earnings release?

Shockwave Medical's Fourth Quarter 2021 earnings release is on February 17, 2022, at 4:30 p.m. ET.

What are the dates for Shockwave Medical's upcoming earnings calls?

The upcoming earnings calls are scheduled for February 17, 2022; May 9, 2022; August 8, 2022; and November 7, 2022, all at 4:30 p.m. ET.

How can investors listen to Shockwave Medical's earnings calls?

Investors can listen to the earnings calls by dialing (866) 795-9106 for domestic callers or (470) 495-9173 for international callers, and using conference ID: 6866777.

What is Intravascular Lithotripsy (IVL)?

Intravascular Lithotripsy (IVL) is a minimally invasive treatment developed by Shockwave Medical for calcified cardiovascular disease, using sonic pressure waves.